Q32 Bio Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Q32 Bio Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $1.16 million for the year ending 2023.

  • Q32 Bio Inc. showed a decrease of -64.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2022 to 2023.
  • This data is from Q32 Bio Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2024.
  • XBRL data for this metric is available from 2018 to 2023 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2018 to 2023), Q32 Bio Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 78.3%.
  • Historical annual values: Fiscal year 2023: $1.16 million | Fiscal year 2022: $3.21 million | Fiscal year 2021: $33.97 million | Fiscal year 2020: $2.70 million | Fiscal year 2019: $1.67 million | Fiscal year 2018: $5.32 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: